Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/08/2009US20090252790 Tablet formulation
10/08/2009US20090252788 Balsalazide formulations and manufacture and use thereof
10/08/2009US20090252787 Granular pharmaceutical compositions
10/08/2009US20090252785 Endoplasmic reticulum targeting liposomes
10/08/2009US20090252784 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
10/08/2009US20090252783 Means for inhibiting the expression of cd31
10/08/2009US20090252781 Hydrogel polymeric compositions and methods
10/08/2009US20090252779 Azaindazole compounds and methods of use
10/08/2009US20090252778 Methods and devices for reducing tissue damage after ischemic injury
10/08/2009US20090252773 Emulsion composition
10/08/2009US20090252768 Use of stilbene derivatives for treatment and prevention of aquatic mold infections
10/08/2009US20090252757 Methods and compositions for inhibiting hiv infection
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252721 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
10/08/2009US20090252716 Methods for identifying nuclear receptor/ligand combinations for targeting brain tumor stem cells and for their use
10/08/2009US20090252714 Autoantigenes for Improved Diagnosis, Prognosis and Treatment of Inflammatory Neurological Diseases
10/08/2009US20090252707 Novel expression vectors and uses thereof
10/08/2009US20090252706 Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
10/08/2009US20090252704 Therapies for cognition and learning enhancement
10/08/2009US20090252702 Polymer-based anti-cancer agents
10/08/2009US20090252700 Hydroxyphenyl cross-linked macromolecular network and applications thereof
10/08/2009US20090252699 Medical devices with an antimicrobial polyurethane coating
10/08/2009US20090252694 Novel Chalcone Derivatives, Pharmaceutically Acceptable Salt, Method for Preparation and Uses Thereof
10/08/2009US20090252692 Esterified fatty acid composition
10/08/2009US20090252685 High penetration prodrug compositions of prostaglandins and related compounds
10/08/2009US20090252684 Determination of tissue-specific profile of amino acid requirements form the relationship between the amounts of tRNAs for individual amino acids and the protein-bound amino acid profile of the tissue
10/08/2009US20090252672 Nasal delivery of therapeutic agents using tight junction agonists
10/08/2009DE102008017590A1 Glucopyranosidderivate Glucopyranosidderivate
10/08/2009CA2757442A1 Use of ribose in first response to acute myocardial infarction
10/08/2009CA2728890A1 Amide derivative-containing pharmaceutical composition
10/08/2009CA2728889A1 Solid state forms of a pharmaceutical
10/08/2009CA2723134A1 Novel dna capable of being amplified by pcr with high selectivity and high efficiency
10/08/2009CA2720632A1 Halichondrin b analogs
10/08/2009CA2720527A1 Inhibitors of peritoneal seeding of cancer cells
10/08/2009CA2720490A1 Compounds and compositions as itpkb inhibitors
10/08/2009CA2720480A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/08/2009CA2720473A1 Compositions and use of epas1 inhibitors
10/08/2009CA2720464A1 Gabaa receptor modulators
10/08/2009CA2720461A1 New classes of gabaa/bzr ligands
10/08/2009CA2720418A1 Pharmaceutical composition with bisphosphonate
10/08/2009CA2720410A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
10/08/2009CA2720396A1 Pharmaceutical composition
10/08/2009CA2720390A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
10/08/2009CA2720375A1 Compounds for treating pain
10/08/2009CA2720359A1 Liver cancer drug
10/08/2009CA2720350A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720301A1 Dispersinb tm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
10/08/2009CA2720278A1 Agent for preventing and/or treating vascular diseases
10/08/2009CA2720275A1 Indolinone compound
10/08/2009CA2720176A1 Antiproliferative compounds and therapeutic uses thereof
10/08/2009CA2720164A1 Processes for preparing sunitinib and salts thereof
10/08/2009CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof
10/08/2009CA2720037A1 Purine derivatives as a3 adenosine receptor-selective agonists
10/08/2009CA2720030A1 Device for in situ production and topical administration of allicin
10/08/2009CA2720011A1 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009CA2719985A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009CA2719963A1 Double-stranded lipid-modified rna having high rna interference effect
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719666A1 Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
10/08/2009CA2719608A1 Orodispersable formulations of phosphodiesterase-5 (pde-5) inhibitors
10/08/2009CA2719507A1 Oxymethylene aryl compounds and uses thereof
10/08/2009CA2719362A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009CA2719358A1 Antiviral agent and antiviral composition
10/08/2009CA2719252A1 Anti-infective agents and uses thereof
10/08/2009CA2719216A1 Compositions and methods for treatment of neoplastic disease
10/08/2009CA2719070A1 Substituted piperidines as therapeutic compounds
10/08/2009CA2719032A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/08/2009CA2718826A1 Gatifloxacin-containing aqueous liquid preparation
10/08/2009CA2718753A1 Novel oral controlled release pharmaceutical formulations
10/08/2009CA2718645A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009CA2718641A1 Gatifloxacin-containing aqueous liquid preparation, its production and method for suppressing formation of precipitate during storage at lower temperature and at the time of freezing and thawing of the aqueous liquid preparation
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2718310A1 Pyridyl derivatives as cftr modulators
10/08/2009CA2717537A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/08/2009CA2716410A1 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/08/2009CA2715584A1 Oral controlled release tablet
10/08/2009CA2714996A1 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
10/08/2009CA2712071A1 Antiviral drugs for treatment of arenavirus infection
10/08/2009CA2685716A1 Compounds for treating muscular dystrophy
10/07/2009EP2107072A1 Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same
10/07/2009EP2107057A1 Process for the preparation of pure duloxetine hydrochloride
10/07/2009EP2107055A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
10/07/2009EP2107054A1 Antiproliferative compounds and therapeutic uses thereof
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009EP2107050A1 Lipoxin compounds
10/07/2009EP2106805A1 Antifungal nail coat and method of use
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106798A1 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
10/07/2009EP2106797A2 Controlled release oxycodone compositions
10/07/2009EP2106796A2 Controlled release oxycodone compositions
10/07/2009EP2106795A1 Use of phthalide dipolymers for antitumor
10/07/2009EP2106794A1 Ubiquitin alone or in combination for use in the treatment of sweet itch.
10/07/2009EP2106793A1 Ready to use Oxaliplatin solutions
10/07/2009EP2106792A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
10/07/2009EP2106791A1 Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation
10/07/2009EP2106789A1 Pharmaceutical composition comprising candesartan
1 ... 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 ... 7860